Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ DCPS Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA558865
Description
Immunogen sequence: QLGKRKRELD VEEAHAASTE EKEAGVGNGT CAPVRLPFSG FRLQKVLRES ARDKIIFLHG KVNEASGDGD GEDAVVILEK TPFQVEQVAQ LLTGSPE Highest antigen sequence identity to the following orthologs: Mouse - 85%, Rat - 82%.
Necessary for the complete degradation of mRNAs, both in normal mRNA turnover and in nonsense-mediated mRNA decay. Removes the 7-methyl guanine cap structure from mRNA fragments shorter than 10 nucleotides that are produced by 3'->5' exosome-mediated mRNA decay. Releases m7GMP. Can also degrade m7GDP to m7GMP. Has no activity towards mRNA molecules longer than 25 nucleotides.
Specifications
DCPS | |
Polyclonal | |
Unconjugated | |
DCPS | |
5'-(N(7)-methyl 5'-triphosphoguanosine)-[mRNA] diphosphatase; ARS; Dcps; DCS1; DCS-1; decapping enzyme, scavenger; decapping scavenger enzyme; heat shock-like protein 1; HINT5; HINT-5; Hint-related 7meGMP-directed hydrolase; Histidine triad nucleotide-binding protein 5; histidine triad protein member 5; homolog of C. elegans 7meGMP-directed hydrolase dcs-1; HSL1; HSPC015; m7GpppX diphosphatase; mRNA decapping enzyme; scavenger mRNA-decapping enzyme DcpS | |
Rabbit | |
Antigen Affinity Chromatography | |
RUO | |
28960 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Western Blot, Immunocytochemistry | |
0.1 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q96C86 | |
DCPS | |
Recombinant protein corresponding to Human DCPS. Recombinant protein control fragment (Product #RP-97297). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction